Literature DB >> 20371598

Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration.

Maurizio Brigotti1, Pier Luigi Tazzari, Elisa Ravanelli, Domenica Carnicelli, Stefania Barbieri, Laura Rocchi, Valentina Arfilli, Gaia Scavia, Francesca Ricci, Andrea Bontadini, Roberta R Alfieri, Pier Giorgio Petronini, Carmine Pecoraro, Alberto E Tozzi, Alfredo Caprioli.   

Abstract

The endothelial damage induced by Stx represents the main pathogenic event in the HUS associated with STEC infections in humans. Stx, released in the gut by bacteria, enter the bloodstream and are targeted to renal endothelia. The role of PMN as a toxin carrier has been the object of controversy. In this paper, we confirm the binding of Stx1 to PMN, also showing its degranulating effects on full-loaded leukocytes, and support the carrier role of PMN by using a two-chamber transmigration device, in which PMN, loaded in vitro with different amounts of Stx1, transmigrated through confluent monolayers of endothelial cells, mimicking the toxin-induced renal endothelial injury. Stx1 was transferred during PMN transmigration, impairing protein synthesis and triggering production of proinflammatory cytokines in endothelial cells. PMN, carrying low toxin amounts, induced the release of high levels of cytokines in viable endothelial cells, whereas cytokine production was blocked in cells challenged with PMN fully loaded with Stx as a result of an almost total impairment of translation and of the activation of the apoptotic program. In agreement with previous unexplained observations in animal models, the results obtained with our experimental setting suggest that a self-amplifying circle triggered by low doses of toxin may lead to the production of proinflammatory mediators of renal damage in HUS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371598     DOI: 10.1189/jlb.0709475

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Valentina Arfilli; Laura Rocchi; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Antonio González Vara; Matteo Amelia; Francesco Manoli; Sandra Monti
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Authors:  Maria Victoria Ramos; Maria Pilar Mejias; Florencia Sabbione; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Maria Marta Amaral; Ramon Exeni; Analia Silvina Trevani; Marina Sandra Palermo
Journal:  J Innate Immun       Date:  2016-05-28       Impact factor: 7.349

4.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.

Authors:  Josefine Betz; Martina Bielaszewska; Andrea Thies; Hans-Ulrich Humpf; Klaus Dreisewerd; Helge Karch; Kwang S Kim; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

Review 7.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

8.  Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Authors:  Deborah J Stearns-Kurosawa; Sun-Young Oh; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh; James Papin; Joel Henderson; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2013-02-10       Impact factor: 4.307

Review 9.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

10.  Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.

Authors:  Diana Karpman
Journal:  Nephrol Dial Transplant       Date:  2012-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.